Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Angiodynamics (ANGO) Invested Capital (2016 - 2025)

Historic Invested Capital for Angiodynamics (ANGO) over the last 17 years, with Q4 2025 value amounting to $176.3 million.

  • Angiodynamics' Invested Capital fell 802.96% to $176.3 million in Q4 2025 from the same period last year, while for Nov 2025 it was $176.3 million, marking a year-over-year decrease of 802.96%. This contributed to the annual value of $183.0 million for FY2025, which is 1100.07% down from last year.
  • Per Angiodynamics' latest filing, its Invested Capital stood at $176.3 million for Q4 2025, which was down 802.96% from $178.9 million recorded in Q3 2025.
  • Angiodynamics' 5-year Invested Capital high stood at $454.9 million for Q1 2021, and its period low was $176.3 million during Q4 2025.
  • In the last 5 years, Angiodynamics' Invested Capital had a median value of $414.2 million in 2022 and averaged $335.9 million.
  • Per our database at Business Quant, Angiodynamics' Invested Capital soared by 228.28% in 2022 and then plummeted by 5344.03% in 2024.
  • Quarter analysis of 5 years shows Angiodynamics' Invested Capital stood at $432.4 million in 2021, then dropped by 3.39% to $417.7 million in 2022, then fell by 1.7% to $410.6 million in 2023, then tumbled by 53.31% to $191.7 million in 2024, then decreased by 8.03% to $176.3 million in 2025.
  • Its Invested Capital stands at $176.3 million for Q4 2025, versus $178.9 million for Q3 2025 and $183.0 million for Q2 2025.